The website of Pathology In Practice Magazine

Parathyroid hormone assay control

Parathyroid hormone (PTH) is a notoriously unstable and inconsistent assay, with many control products failing to meet the demands of today’s busy laboratory. Quality control is a passion at Randox and as such the company has developed a new solution to the stability problems experienced with PTH.

The Randox Acusera PTH Control has been manufactured with user convenience in mind, providing a liquid frozen control with 30-day, open-vial stability. Acusera PTH Control provides a true third-party solution for the measurement of intact PTH, and deliver an unbiased, independent assessment of analytical performance with any instrument or method.

Features of the Acusera PTH Control include liquid for ease-of-use, true third-party control providing unbiased performance assessment, assayed target values for many immunoassay platforms, and 30-day, open-vial stability at 2OC to 8OC.

www.randoxqc.com

Upcoming Events

Every Minute Counts: a SHOT, BBTS and NBTC joint webinar

Online
3 December 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Every Minute Counts: a SHOT, BBTS and NBTC joint webinar

Online
3 December 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2021 Step Communications Ltd. Registered in England. Registration Number 3893025